• Hypertrophic Cardiomyopathy (HCM)
  • Eyecare
  • Urothelial Carcinoma
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Asthma
  • Atrial Fibrillation
  • COVID-19
  • Cardiovascular Diseases
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

MCOs collect racial data to close disparities within care


Washington, D.C.-Not too long ago, an insurer or HMO that requested information on a patient’s race or ethnicity could be accused of racial profiling or cream-skimming. Today health plans are highlighting their programs for collecting such data to improve quality of care for racial and ethnic groups. Last month, AHIP (America’s Health Insurance Plans) and the Robert Wood Johnson Foundation released a survey indicating that most (51%) MCOs collect data on member race and ethnicity in order to target certain demographic groups for special preventive health- and disease-management programs.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.